Molecular subtyping in urothelial carcinoma treatment

被引：1
|
作者：
Wu, Xiaowen [1 ]
Sheng, Xinan [1 ]
机构：
[1] Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Dept Genitourinary Oncol, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
来源：
CANCER CELL | 2024年 / 42卷 / 12期
关键词：
D O I：
10.1016/j.ccell.2024.11.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The heterogeneity of urothelial carcinoma (UC) and variable treatment responses poses significant clinical challenges. In this issue of Cancer Cell, Hamidi et al. conducted a multi-omics analysis of 2,803 UC patients from four clinical trials with anti-PD-L1, revealing four transcriptional subtypes. This approach could help tailor therapies for UC.
引用
收藏
页码：1993 / 1996
页数：4
相关论文
共 50 条
  • [1] Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes
    Takahara, Taishi
    Murase, Yota
    Tsuzuki, Toyonori
    PATHOLOGY, 2021, 53 (01) : 56 - 66
  • [2] Molecular subtyping of urothelial bladder carcinoma in young patients
    Shelekhova, K.
    Mescherjakov, I. A.
    Mitin, N. P.
    VIRCHOWS ARCHIV, 2017, 471 : S27 - S27
  • [3] Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: A paradigm for molecular subtyping of urothelial cell carcinoma of the bladder
    Adam, Rosalyn M.
    DeGraff, David J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (10) : 444 - 450
  • [4] Molecular Pathologic Subtyping of Urothelial Bladder Carcinoma in Young Patients
    Shelekhova, Ksenya V.
    Krykow, Kirill A.
    Mescherjakov, Igor A.
    Mitin, Nikolay P.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2019, 27 (05) : 483 - 491
  • [5] Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice
    Francisco Javier Queipo
    Gorka Muñiz Unamunzaga
    Begoña Fuertes Negro
    Sandra Gracia Fuertes
    Marina Álvarez Cortés
    Elena Carceller Tejedor
    Carmen María Bernal Mañas
    Arceli Bono Ariño
    Gottfrid Sjödahl
    Carmen Beorlegui
    Virchows Archiv, 2022, 481 : 191 - 200
  • [6] Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice
    Queipo, Francisco Javier
    Unamunzaga, Gorka Muniz
    Negro, Begona Fuertes
    Fuertes, Sandra Gracia
    Cortes, Marina alvarez
    Tejedor, Elena Carceller
    Manas, Carmen Maria Bernal
    Arino, Arceli Bono
    Sjodahl, Gottfrid
    Beorlegui, Carmen
    VIRCHOWS ARCHIV, 2022, 481 (02) : 191 - 200
  • [7] Upper tract urothelial cancer (UTUC): Role of sequencing, molecular subtyping and treatment outcomes
    Belay, Sarah
    Li, Wenping
    Aragon-Ching, Jeanny B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Molecular subtyping of metastatic urothelial bladder cancer.
    Ackerman, Charlotte
    Mariathasan, Sanjeev
    Nickles, Dorothee
    Lista, Alfonso Gomez De Liano
    Wimalasingham, Akhila Ganeshi
    Szabados, Bernadett
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [9] Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications
    Weiss, Kristin
    Gessner, Kathryn H.
    Demzik, Alysen
    Moreton, Elizabeth
    Kim, William Y.
    Wobker, Sara E.
    Rose, Tracy L.
    Milowsky, Matthew I.
    Bjurlin, Marc A.
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 37
  • [10] A Molecular Taxonomy for Urothelial Carcinoma
    Sjodahl, Gottfrid
    Lauss, Martin
    Lovgren, Kristina
    Chebil, Gunilla
    Gudjonsson, Sigurdur
    Veerla, Srinivas
    Patschan, Oliver
    Aine, Mattias
    Ferno, Marten
    Ringner, Markus
    Mansson, Wiking
    Liedberg, Fredrik
    Lindgren, David
    Hoglund, Mattias
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3377 - 3386
12345